{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:28:09Z","timestamp":1793330889349,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.annder.2015.10.588","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T02:50:41Z","timestamp":1449197441000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Gales en \u00e9chec de traitement\u00a0: \u00e9tude observationnelle"],"prefix":"10.1016","volume":"143","author":[{"given":"B.","family":"De Sainte Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gaudy-Marqueste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Baumstarck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bentaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Loundou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Monestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-J.","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-A.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2015.10.588_bib0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.annder.2012.01.023","article-title":"La gale en France entre 1999\u00a0et 2010\u00a0: augmentation de l\u2019incidence et implications en sant\u00e9 publique","volume":"139","author":"Bitar","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2015.10.588_bib0095","series-title":"Causes d\u2019\u00e9chec th\u00e9rapeutique de la gale en p\u00e9diatrie. Communication orale. S\u00e9ance de la Soci\u00e9t\u00e9 fran\u00e7aise de dermatologie. S\u00e9ance de dermatologie p\u00e9diatrique du 16\u00a0janvier 2014. Paris","author":"H\u00e9riss\u00e9","year":"2014"},{"key":"10.1016\/j.annder.2015.10.588_bib0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.2.4211.405","article-title":"The transmission of scabies","volume":"2","author":"Mellanby","year":"1941","journal-title":"BMJ"},{"key":"10.1016\/j.annder.2015.10.588_bib0105","series-title":"Recommandations relatives \u00e0 la conduite \u00e0 tenir devant un ou plusieurs cas de, gale. Haut Conseil de Sant\u00e9 Publique","year":"2012"},{"key":"10.1016\/j.annder.2015.10.588_bib0110","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(00)90131-2","article-title":"A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies","volume":"42","author":"Usha","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2015.10.588_bib0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4103\/0378-6323.84063","article-title":"Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study","volume":"77","author":"Sharma","year":"2011","journal-title":"Ind J Dermatol Venereol Leprol"},{"key":"10.1016\/j.annder.2015.10.588_bib0120","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1086\/421776","article-title":"First documentation of in vivo and in vitro ivermectine resistance in Sarcoptes scabiei","volume":"39","author":"Currie","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annder.2015.10.588_bib0125","first-page":"331","article-title":"Comparison of ivermectin and benzyl benzoate for treatment of scabies","volume":"44","author":"Glaziou","year":"1993","journal-title":"Trop Med Parasitol"},{"key":"10.1016\/j.annder.2015.10.588_bib0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1440-1754.2002.00015.x","article-title":"Ivermectin is better than benzyl benzoate for childhood scabies in developing countries","volume":"38","author":"Brooks","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.annder.2015.10.588_bib0135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2471\/BLT.08.052308","article-title":"Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial","volume":"87","author":"Ly","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.annder.2015.10.588_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/004947550103100105","article-title":"Successful treatment of scabies with oral ivermectin in Nigeria","volume":"31","author":"Nnoruka","year":"2001","journal-title":"Trop Doct"},{"key":"10.1016\/j.annder.2015.10.588_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0253-7613.48882","article-title":"Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies","volume":"41","author":"Bachewar","year":"2009","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.annder.2015.10.588_bib0150","first-page":"69","article-title":"Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigator-blinded, comparative trial vs. permethrin cream","volume":"13","author":"Amerio","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.annder.2015.10.588_bib0155","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1468-3083.2006.01623.x","article-title":"Efficacy and tolerability of a new synergized pyrethrins thermofobic foam in comparison with benzyl benzoate in the treatment of scabies in convicts: the ISAC study (Studio Della scabbia in ambiente carcerario)","volume":"20","author":"Biele","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2015.10.588_bib0080","first-page":"CD000320","article-title":"Interventions for treating scabies","volume":"3","author":"Strong","year":"2007","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963815011424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963815011424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:04:07Z","timestamp":1758971047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963815011424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0151963815011424"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2015.10.588","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gales en \u00e9chec de traitement\u00a0: \u00e9tude observationnelle","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2015.10.588","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}